MXene‐Based Photothermal‐Responsive Injectable Hydrogel Microsphere Modulates Physicochemical Microenvironment to Alleviate Osteoarthritis
Zehua Gong,
No information about this author
Linjie Chen,
No information about this author
Xiaolei Zhou
No information about this author
et al.
Smart Medicine,
Journal Year:
2025,
Volume and Issue:
4(2)
Published: April 13, 2025
ABSTRACT
Osteoarthritis
(OA)
is
a
physical
lubrication
microenvironment‐inadequate
disease
accompanied
by
sustained
chronic
chemical
inflammation
microenvironment
and
the
progression
of
articular
cartilage
destruction.
Despite
promising
OA
treatment
outcomes
observed
in
enhancement
inspired
ball
bearings
to
reduce
friction
support
loads,
therapeutic
effect
near‐infrared
(NIR)
irradiation‐based
photothermal‐responsive
controlled
release
“smart
hydrogel
microspheres”
on
remains
unclear.
Here,
we
prepared
MXene/NIPIAM‐based
injectable
microspheres
encapsulating
diclofenac
sodium
using
microfluidic
system.
Consequently,
NIR
demonstrate
beneficial
effects
modulating
microenvironment,
laying
foundation
for
application
smart
microsphere
delivery
systems
loaded
with
bioactive
factors
(including
agents,
cells,
factors)
regulate
multiple
pathological
microenvironments
regenerative
medicine.
Language: Английский
Engineered Stem Cell Clusters for Extracellular Vesicles‐Mediated Gene Delivery to Rejuvenate Chondrocytes and Facilitate Chondrogenesis in Osteoarthritis Therapy
Yuezhou Wu,
No information about this author
Yubo Feng,
No information about this author
Fei Hu
No information about this author
et al.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 25, 2025
Abstract
Gene
therapy
offers
an
ideal
potential
treatment
strategy
for
osteoarthritis
(OA).
However,
the
safe
and
efficient
delivery
of
therapeutic
genes
remains
highly
challenging
because
inactivation
in
direct
miRNA,
low
transfection
efficiency,
a
short
half‐life.
This
study
introduced
gene
using
mesenchymal
stem
cells
(MSCs)
as
platform
achieved
sustained
via
engineered
MSCs‐derived
extracellular
vesicles
(EVs).
The
miRNA‐874‐3p
is
combined
with
exosome‐targeting
motif
transfected
into
bone
marrow
(BMSCs).
BMSCs
motif+miR874
are
then
seeded
onto
hydrogel
microspheres,
creating
BMSC
/MS
system
OA
treatment.
In
vitro
experiments
demonstrated
that
not
only
alleviated
inflammation
oxidative
stress‐induced
damage
to
chondrocytes
by
downregulating
NF‐κB
signaling
pathway,
thereby
rejuvenating
chondrocytes,
but
also
promoted
chondrogenesis
inflammatory
microenvironment.
Furthermore,
prolonged
retention
vivo,
enabling
gene,
miRNA‐874‐3p,
over
extended
duration.
rat
model,
successfully
delivered
articular
cartilage
effectively
degeneration.
conclusion,
this
EVs‐mediated
approach
enables
miRNA‐based
viable
alternative
surgery
provides
novel
option
therapy.
Language: Английский
Macrophage Membrane‐Biomimetic Multi‐Layered Nanoparticles Targeting Synovial Angiogenesis for Osteoarthritis Therapy
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 14, 2024
Abstract
Osteoarthritis
(OA)
is
an
inflammatory
and
progressive
joint
disease
characterized
by
angiogenesis‐mediated
sustained,
chronic,
low‐grade
synovitis.
Anti‐angiogenesis
emerging
as
a
strategy
for
attenuating
OA
progression,
but
often
compromised
poor
targeted
drug
delivery
immune
clearance.
Recent
studies
have
identified
macrophages
formed
“protective
barrier”
in
the
lining
layer
(LL)
of
synovium,
which
blocked
communication
cavity
sublining
(SL)
synovium.
Inspired
natural
mimicry,
macrophage
membrane‐camouflaged
explored
to
avoid
Based
on
single
cell
RNA
sequencing,
CD34
+
synovial
cells
are
“sentinel
cells”
synovium
angiogenesis.
Consequently,
antibody‐modified
membrane
constructed
target
new
Hence,
biomimetic
multi‐layered
nanoparticle
(NP)
developed
that
incorporates
axitinib‐loaded
poly(lactic‐co‐glycolic)
acid
(PLGA)
with
antibody
modified
(Atb@NP@Raw@CD34)
specifically
deliver
axitinib
(Atb)
SL
sustain
inhibiting
angiogenesis
without
elimination.
It
found
Atb@NP@Raw@CD34
can
pass
through
“barrier”,
targeting
cells,
continuously
releasing
Atb
anti‐angiogenesis
Furthermore,
vivo
data
demonstrated
attenuate
degeneration
In
conclusion,
local
injection
presents
promising
approach
clinically
impeding
progression.
Language: Английский
Combating Cellular Aging: Frontiers in Biomaterials and Therapies
ACS Materials Letters,
Journal Year:
2024,
Volume and Issue:
7(1), P. 1 - 23
Published: Nov. 21, 2024
With
the
continuous
increase
in
average
life
expectancy,
population
aging
has
become
a
significant
health
issue
21st
century.
The
rising
prevalence
of
age-related
diseases
brought
tremendous
pressure
on
social
medical
systems
and
economy.
Against
this
backdrop,
research
anticellular
hot
spot
field
biomedicine,
biomaterials
are
showing
new
trends
potential
area.
Compared
to
drugs
other
traditional
anti-aging
strategies,
can
be
personalized
target
characteristics
different
tissues,
serving
as
drug
delivery
carriers
enhance
targeting,
directly
influence
cellular
process
by
modulating
microenvironment.
Furthermore,
offer
innovative
approaches
diagnosing
building
sophisticated
models,
which
our
understanding
biology
behind
speed
up
advancement
novel
treatments.
This
review
synthesizes
latest
advancements
biomaterial
for
combating
aging,
exploring
future
prospects
challenges.
Language: Английский